Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Search results are limited to:
Abstract Book of the 7th European Myeloma Network Meeting, Prague, 16-18 April 2026
Vol. 111 No. s2
Advanced filters
Search the full archive

P23 | DARA-VTD AND ASCT+ LENALIDOMIDE LED TO HIGH COMPLETE REIMISSION AND MINIMAL RESIDUAL DISEASE NEGATIVITY RATES BY NGF: A REAL-WORLD STUDY OF THE TUSCAN MYELOMA NETWORK IN 228 PATIENTS (284 Online Views)

V. Venanzi1, S. Ciofini1, E. Antonioli2, G. Buda3, E. Bestoso1, D. Raspadori1, V. Candi4, L. Pengue2, M.L. Del Giudice3, A. Caremani4, S. Moretti5, G. Fontanelli5, I. Attucci2, M. T. Pirrotta5, C. Biagiotti5, S. Birtolo5, S. Grammatico5, S. Pilerci6, L. Notarfranchi7, G. Tancredi3, S. Galimberti3, M. Bocchia1, A. Gozzetti1

1 Department of Medicine Surgery and Neuroscience, Hematology, University of Siena, Italy
2 Department of Hematology, Careggi Hospital and University of Florence, Italy
3 Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Italy
4 Hematology Unit,Ospedale S. Donato, Arezzo, Italy
5 USL Toscana Centro, SOC Oncoematologia, Italy
6 Hematology Ospedale della Versilia, Lucca, Italy
7 Hematology Massa Carrara, Italy
CASSIOPEIA Trial Multiple Myeloma Tuscan network DARA-VTD
1 - 1 of 1 items
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online